Health Sciences Research Group-Primary Care, University of Manchester, Manchester M13 9PL, UK.
BMJ. 2012 Apr 17;344:e2405. doi: 10.1136/bmj.e2405.
To examine the reasons why practices exempt patients from the UK Quality and Outcomes Framework pay for performance scheme (exception reporting) and to identify the characteristics of general practices associated with informed dissent.
Retrospective analysis.
Data for 2008-9 extracted from the clinical computing systems of general practices in England.
8229 English family practices.
Rates of exception reporting for 37 clinical quality indicators, associations of patient and general practice factors with exception rates, and financial gain for practices relating to their use of exception reporting.
The median rate of exception reporting was 2.7% (interquartile range 1.9-3.9%) overall and 0.44% (0.14-1.1%) for informed dissent, but variation in rates was wide between practices and across indicators. Common reasons for exception reporting were logistical (40.6% of exceptions), clinical contraindication (18.7%), and patient informed dissent (30.1%). Higher rates of informed dissent were associated with: higher numbers of registered patients, higher levels of local area deprivation, and failure of the practice to secure maximum remuneration in the previous year. Exception reporting increased the cost of the scheme by £30,844,500 (€36,877,700; $49,053,200) (£0.58 per patient), with two indicators accounting for a quarter of this additional cost.
The provision to exception report enables practices to exempt dissenting patients without being financially penalised. Relatively few patients were excluded for informed dissent, however, suggesting that the incentivised activities were broadly acceptable to patients.
探讨实践豁免患者参加英国质量和结果框架绩效付费计划(例外报告)的原因,并确定与知情异议相关的一般实践特征。
回顾性分析。
2008-2009 年从英格兰一般实践的临床计算系统中提取的数据。
8229 家英国家庭实践。
37 项临床质量指标的例外报告率,患者和一般实践因素与例外报告率的关联,以及实践在使用例外报告方面的财务收益。
例外报告的中位数率总体为 2.7%(四分位距 1.9-3.9%),知情异议为 0.44%(0.14-1.1%),但实践之间和指标之间的差异很大。例外报告的常见原因包括后勤原因(40.6%的例外)、临床禁忌(18.7%)和患者知情异议(30.1%)。知情异议较高的原因包括:登记患者人数较多、当地区域贫困程度较高以及上一年未能获得最大报酬。例外报告增加了该计划的成本 30844500 英镑(€36877700;$49053200)(每位患者 0.58 英镑),其中两个指标占这一额外成本的四分之一。
提供例外报告使实践能够在不被财务处罚的情况下豁免持不同意见的患者。然而,相对较少的患者因知情异议而被排除在外,这表明激励措施在很大程度上被患者所接受。